---
schema_version: "secwatch.filing_event.v1"
accession: "0000920148-26-000201"
form_type: "8-K"
ticker: "LH"
cik: "0000920148"
company_name: "LABCORP HOLDINGS INC."
filed_at: "2026-09-10T20:47:55+00:00"
generated_at: "2026-09-10T20:49:24.317422+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Labcorp Investor Day: 5-8% revenue CAGR through 2029, reaffirms 2026 guidance

## Summary
- Reaffirms 2026 guidance: revenue $14.71-14.83B (5.4-6.3% growth), adjusted EPS $18.10-18.55, FCF $1.24-1.36B.
- Long-term outlook through 2029: 5-8% compound annual revenue growth, 8.5-11.5% adjusted EPS CAGR.
- Targets 75-150 bps adjusted operating margin expansion by end of 2029; FCF growth in line with adjusted earnings.
- Strategic priorities: specialty testing (oncology, neurology, autoimmune, women's health), health-system partnerships, AI/robotics.
- CEO Adam Schechter cites above-market growth expectation; CFO Julia Wang details disciplined capital deployment framework.

## SEC filing metadata
- accession: 0000920148-26-000201
- form_type: 8-K
- ticker: LH
- cik: 0000920148
- company_name: LABCORP HOLDINGS INC.
- filed_at: 2026-09-10T20:47:55+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/920148/000092014826000201/0000920148-26-000201-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/920148/000092014826000201/lh-20260910.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000920148-26-000201
- JSON: https://secwatch.observer/filing/0000920148-26-000201.json
- Plain text: https://secwatch.observer/filing/0000920148-26-000201.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.